Decreased and dysfunctional circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease

Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functi...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 126; no. 17; pp. 3222 - 3227
Main Authors YANG, Yue, GAN, Ye, CAO, Jun, CHEN, Yan, HE, Zhi-hui, LUO, Hong, CAI, Shan, XIANG, Xu-dong, ZHOU, Rui, CHEN, Ping
Format Journal Article
LanguageEnglish
Published China Department of Geriatrics, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Departement of Rehabilitation Medicine, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Respiratory Medicine, Hunan Provincial People's Hospital, Changsha, 410005, China%Department of Respiratory Medicine ,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Intensive Care Unit,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China 2013
Subjects
Online AccessGet full text
ISSN0366-6999
2542-5641
2542-5641
DOI10.3760/cma.j.issn.0366-6999.20122633

Cover

Abstract Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functions of circulating endothelial progenitor calls in patients with chronic obstructive pulmonary disease. Methods The total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects. The number of circulating endothelial progenitor cells (CD34+/CD133+/IVEGFR-2+cells) was counted by flow cytometry. Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of Dil- acLDL, combining with UEA-I, and expression of von Willebrand factor and endothelial nitric oxide synthase. Adhesion, proliferation, production of nitric oxide, and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease. Results The number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group: (0.54±0.16)% vs. (1.15±0.57)%, P 〈0.05. About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-I. The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase, respectively. Compared with the control, there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients: 18.7±4.8/field vs. 45.0±5.9/field, P 〈0.05. The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired: 0.135±0.038 vs. 0.224±0.042, P 〈0.05. Furthermore, nitric oxide synthase (112.06±10.00 vs. 135.41±5.38, P 〈0.05), phosphorylated endothelial nitric oxide synthase protein expression (88.89±4.98 vs. 117.98±16.49, P 〈0.05) and nitric oxide production ((25.11±5.27) Iμmol/L vs. (37.72±7.10) μmol/L, P 〈0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control. Conclusion Circulating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.
AbstractList Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications.In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease,we sought to observe the level and functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease.Methods The total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects.The number of circulating endothelial progenitor cells (CD34+/CD133+/VEGFR-2+ cells) was counted by flow cytometry.Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of DilacLDL,combining with UEA-I,and expression of von Willebrand factor and endothelial nitric oxide synthase.Adhesion,proliferation,production of nitric oxide,and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease.Results The number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group:(0.54±0.16)% vs.(1.15±0.57)%,P <0.05.About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-1.The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase,respectively.Compared with the control,there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients:18.7±4.8/field vs.45.0±5.9/field,P <0.05.The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired:0.135±0.038 vs.0.224±0.042,P<0.05.Furthermore,nitric oxide synthase (112.06±10.00 vs.135.41±5.38,P <0.05),phosphorylated endothelial nitric oxide synthase protein expression (88.89±4.98 vs.117.98±16.49,P <0.05) and nitric oxide production ((25.11±5.27) μmol/L vs.(37.72±7.10) μmol/L,P <0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control.Conclusion Circulating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.
It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease. The total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects. The number of circulating endothelial progenitor cells (CD34(+)/CD133(+)/VEGFR-2(+) cells) was counted by flow cytometry. Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of DiIacLDL, combining with UEA-I, and expression of von Willebrand factor and endothelial nitric oxide synthase. Adhesion, proliferation, production of nitric oxide, and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease. The number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group: (0.54 ± 0.16)% vs. (1.15 ± 0.57)%, P < 0.05. About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-1. The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase, respectively. Compared with the control, there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients: 18.7 ± 4.8/field vs. 45.0 ± 5.9/field, P < 0.05. The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired: 0.135 ± 0.038 vs. 0.224 ± 0.042, P < 0.05. Furthermore, nitric oxide synthase (112.06 ± 10.00 vs. 135.41 ± 5.38, P < 0.05), phosphorylated endothelial nitric oxide synthase protein expression (88.89 ± 4.98 vs. 117.98 ± 16.49, P < 0.05) and nitric oxide production ((25.11 ± 5.27) µmol/L vs. (37.72 ± 7.10) µmol/L, P < 0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control. Circulating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.
Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functions of circulating endothelial progenitor calls in patients with chronic obstructive pulmonary disease. Methods The total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects. The number of circulating endothelial progenitor cells (CD34+/CD133+/IVEGFR-2+cells) was counted by flow cytometry. Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of Dil- acLDL, combining with UEA-I, and expression of von Willebrand factor and endothelial nitric oxide synthase. Adhesion, proliferation, production of nitric oxide, and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease. Results The number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group: (0.54±0.16)% vs. (1.15±0.57)%, P 〈0.05. About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-I. The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase, respectively. Compared with the control, there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients: 18.7±4.8/field vs. 45.0±5.9/field, P 〈0.05. The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired: 0.135±0.038 vs. 0.224±0.042, P 〈0.05. Furthermore, nitric oxide synthase (112.06±10.00 vs. 135.41±5.38, P 〈0.05), phosphorylated endothelial nitric oxide synthase protein expression (88.89±4.98 vs. 117.98±16.49, P 〈0.05) and nitric oxide production ((25.11±5.27) Iμmol/L vs. (37.72±7.10) μmol/L, P 〈0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control. Conclusion Circulating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.
It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease.BACKGROUNDIt has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease.The total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects. The number of circulating endothelial progenitor cells (CD34(+)/CD133(+)/VEGFR-2(+) cells) was counted by flow cytometry. Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of DiIacLDL, combining with UEA-I, and expression of von Willebrand factor and endothelial nitric oxide synthase. Adhesion, proliferation, production of nitric oxide, and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease.METHODSThe total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects. The number of circulating endothelial progenitor cells (CD34(+)/CD133(+)/VEGFR-2(+) cells) was counted by flow cytometry. Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of DiIacLDL, combining with UEA-I, and expression of von Willebrand factor and endothelial nitric oxide synthase. Adhesion, proliferation, production of nitric oxide, and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease.The number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group: (0.54 ± 0.16)% vs. (1.15 ± 0.57)%, P < 0.05. About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-1. The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase, respectively. Compared with the control, there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients: 18.7 ± 4.8/field vs. 45.0 ± 5.9/field, P < 0.05. The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired: 0.135 ± 0.038 vs. 0.224 ± 0.042, P < 0.05. Furthermore, nitric oxide synthase (112.06 ± 10.00 vs. 135.41 ± 5.38, P < 0.05), phosphorylated endothelial nitric oxide synthase protein expression (88.89 ± 4.98 vs. 117.98 ± 16.49, P < 0.05) and nitric oxide production ((25.11 ± 5.27) µmol/L vs. (37.72 ± 7.10) µmol/L, P < 0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control.RESULTSThe number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group: (0.54 ± 0.16)% vs. (1.15 ± 0.57)%, P < 0.05. About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-1. The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase, respectively. Compared with the control, there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients: 18.7 ± 4.8/field vs. 45.0 ± 5.9/field, P < 0.05. The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired: 0.135 ± 0.038 vs. 0.224 ± 0.042, P < 0.05. Furthermore, nitric oxide synthase (112.06 ± 10.00 vs. 135.41 ± 5.38, P < 0.05), phosphorylated endothelial nitric oxide synthase protein expression (88.89 ± 4.98 vs. 117.98 ± 16.49, P < 0.05) and nitric oxide production ((25.11 ± 5.27) µmol/L vs. (37.72 ± 7.10) µmol/L, P < 0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control.Circulating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.CONCLUSIONCirculating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.
Author GAN Ye CAO Jun CHEN Yan HE Zhi-hui LUO Hong CAI Shan XIANG Xu-dong ZHOU Rui CHEN Ping YANG Yue
AuthorAffiliation Department of Geriatrics , Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China Departement of Rehabilitation Medicine, Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China Department of Respiratory Medicine, Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China Department of Intensive Care Unit, Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China Department of Emergency Medicine , Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China Department of Respiratory Medicine, Hunan Provincial People's Hospital, Changsha, 410005, China
AuthorAffiliation_xml – name: Department of Geriatrics, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Departement of Rehabilitation Medicine, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Respiratory Medicine, Hunan Provincial People's Hospital, Changsha, 410005, China%Department of Respiratory Medicine ,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Intensive Care Unit,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China
Author_xml – sequence: 1
  givenname: Yue
  surname: YANG
  fullname: YANG, Yue
– sequence: 2
  givenname: Ye
  surname: GAN
  fullname: GAN, Ye
– sequence: 3
  givenname: Jun
  surname: CAO
  fullname: CAO, Jun
– sequence: 4
  givenname: Yan
  surname: CHEN
  fullname: CHEN, Yan
– sequence: 5
  givenname: Zhi-hui
  surname: HE
  fullname: HE, Zhi-hui
– sequence: 6
  givenname: Hong
  surname: LUO
  fullname: LUO, Hong
– sequence: 7
  givenname: Shan
  surname: CAI
  fullname: CAI, Shan
– sequence: 8
  givenname: Xu-dong
  surname: XIANG
  fullname: XIANG, Xu-dong
– sequence: 9
  givenname: Rui
  surname: ZHOU
  fullname: ZHOU, Rui
– sequence: 10
  givenname: Ping
  surname: CHEN
  fullname: CHEN, Ping
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24033940$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u1DAUhS1URKeFV0BmAWKTwT-J3SxYoOFXqsQG1pZj30wcJfbUdqgKL4-jmc6CFStL1nePfe53hS588IDQa0q2XAryzsx6O25dSn5LuBCVaNt2ywhlTHD-BG1YU7OqETW9QJszcImuUhoJYU0jxTN0yWrCeVuTDfrzEUwEncBi7S22D6lfvMkueD1h46JZJp2d32PwNuQBJlfuDzHswbscIjYwTQk7jw8FA58Tvnd5wGaIwTuDQ5dyXEreL8CHZZpLbHzA1qX1yefoaa-nBC9O5zX6-fnTj93X6vb7l2-7D7eVqbnMlew4ta0FwRq4oZJ0rLGC1Y2QLedUdAwENNL2XBtCuxYYrSm1TPdNRyQnPb9Gb46599r32u_VGJZY-iX1ezDzWJbHSyxpCvj2CJaCdwukrGaX1obaQ1iSojXnTJYNy4K-PKFLN4NVh-jmUk09brYA74-AiSGlCP0ZoUStJlUxqUa1mlSrKLWKUo8my_zun3njsl7F5Kjd9N8pr04pQ_D7uyLy_I1aEinEDeN_ATfit6w
CitedBy_id crossref_primary_10_1177_1535370215598402
crossref_primary_10_18332_tid_131625
crossref_primary_10_3389_fcvm_2021_649512
crossref_primary_10_18332_tid_174661
crossref_primary_10_1371_journal_pone_0173446
crossref_primary_10_1371_journal_pone_0195724
crossref_primary_10_1155_2014_640752
Cites_doi 10.1007/s11010-011-1157-y
10.1016/S1050-1738(03)00077-X
10.1634/stemcells.2005-0440
10.1186/1756-8722-4-24
10.1177/107602960100700304
10.1161/hh1301.093953
10.1093/rheumatology/ken286
10.4103/2045-8932.87295
10.1097/00029330-200804010-00005
10.1007/s00408-009-9225-8
10.1161/01.RES.0000137877.89448.78
10.1161/01.ATV.0000237750.44469.88
10.1513/pats.201101-008MW
10.2217/epi.10.27
10.1007/s00005-007-0027-5
10.1111/j.1440-1843.2011.02032.x
10.1007/s00125-006-0401-6
10.1161/01.CIR.0000097001.79750.78
10.1111/j.1440-1843.2011.01959.x
10.1111/j.1440-1843.2009.01511.x
10.1164/rccm.201002-0222OC
10.1111/j.1582-4934.2004.tb00474.x
10.1183/09031936.06.00120604
10.1164/rccm.201108-1382OC
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.0366-6999.20122633
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Decreased and dysfunctional circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease
EISSN 2542-5641
EndPage 3227
ExternalDocumentID zhcmj201317005
24033940
10_3760_cma_j_issn_0366_6999_20122633
47076682
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: grants from National Natural Science Foundation of China; from the Natural Science Foundation of Hunan Province
  funderid: (81070039,81270100 and 81200026); (2008FJ3152 and 2011SK3237)
GroupedDBID ---
-05
-0E
-SE
-S~
.55
.GJ
29B
2B.
2C~
2RA
2WC
3V.
40I
53G
5GY
5RE
5VR
5VS
6J9
7X7
88E
8FI
8FJ
92F
92I
92L
92M
93N
93R
9D9
9DE
AAHPQ
AASCR
ABASU
ABCQX
ABDIG
ABUWG
ABVCZ
ABXLX
ACGFO
ACGFS
ACILI
ADGGA
ADHPY
ADPDF
ADRAZ
AENEX
AFDTB
AFKRA
AFUIB
AHMBA
AHVBC
AINUH
AJIOK
AJNWD
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
ANFDX
AOHHW
BENPR
BPHCQ
BVXVI
C1A
CAJEE
CAJUS
CCEZO
CCPQU
CHBEP
CIEJG
CQIGP
CW9
DIK
DIWNM
EBS
EEVPB
EJD
F5P
FA0
FCALG
FRP
FYUFA
GNXGY
GQDEL
GROUPED_DOAJ
GX1
HLJTE
HMCUK
HYE
IAO
IHR
IHW
IKREB
INH
INR
IPNFZ
ITC
JUIAU
KQ8
L7B
M1P
M48
OK1
OPUJH
OVD
OVDNE
OVEED
OXXIT
P2P
P6G
PIMPY
PQQKQ
PROAC
PSQYO
PV9
Q--
Q-4
R-E
RIG
RLZ
RNS
RPM
RT5
RZL
S..
T8U
TCJ
TEORI
TGQ
TR2
TSPGW
U1F
U1G
U5E
U5O
UKHRP
W2D
W91
WFFXF
X7J
X7M
XSB
ZA5
ZGI
ZXP
~WA
0R~
AAAAV
AAIQE
AAYXX
ABZZY
ACXJB
AFBFQ
AHQNM
AJCLO
AJZMW
AKCTQ
ALIPV
ALKUP
AOQMC
BQLVK
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
H13
NPM
PHGZM
PHGZT
PJZUB
PPXIY
7X8
ADKSD
4A8
PMFND
PSX
ID FETCH-LOGICAL-c437t-7b31d9de625e8170b25d62456793316b2e6e57df3ac01b9e21411d2af5b0730f3
ISSN 0366-6999
2542-5641
IngestDate Thu May 29 03:55:56 EDT 2025
Mon Sep 08 15:52:26 EDT 2025
Mon Jul 21 05:56:32 EDT 2025
Thu Apr 24 22:58:38 EDT 2025
Tue Jul 01 03:02:57 EDT 2025
Wed Feb 14 10:26:06 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 17
Keywords circulating,endothelial progenitor cells
endothelial nitric oxide synthase
nitric oxide
chronic obstructive pulmonary disease
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c437t-7b31d9de625e8170b25d62456793316b2e6e57df3ac01b9e21411d2af5b0730f3
Notes Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to define the altered pulmonary vascular homeostasis in chronic obstructive pulmonary disease, we sought to observe the level and functions of circulating endothelial progenitor calls in patients with chronic obstructive pulmonary disease. Methods The total study population included 20 patients with chronic obstructive pulmonary disease and 20 control subjects. The number of circulating endothelial progenitor cells (CD34+/CD133+/IVEGFR-2+cells) was counted by flow cytometry. Circulating endothelial progenitor cells were also cultured in vitro and characterized by uptake of Dil- acLDL, combining with UEA-I, and expression of von Willebrand factor and endothelial nitric oxide synthase. Adhesion, proliferation, production of nitric oxide, and expression of endothelial nitric oxide synthase and phosphorylated-endothelial nitric oxide synthase were detected to determine functions of circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease. Results The number of circulating endothelial progenitor cells in the chronic obstructive pulmonary disease group was lower than in the control group: (0.54±0.16)% vs. (1.15±0.57)%, P 〈0.05. About 80% of adherent peripheral blood mononuclear cells cultured in vitro were double labeled with Dil-acLDL and UEA-I. The 92% and 91% of them were positive for von Willebrand factor and endothelial nitric oxide synthase, respectively. Compared with the control, there were significantly fewer adhering endothelial progenitor cells in chronic obstructive pulmonary disease patients: 18.7±4.8/field vs. 45.0±5.9/field, P 〈0.05. The proliferation assay showed that the proliferative capacity of circulating endothelial progenitor cells from chronic obstructive pulmonary disease patients was significantly impaired: 0.135±0.038 vs. 0.224±0.042, P 〈0.05. Furthermore, nitric oxide synthase (112.06±10.00 vs. 135.41±5.38, P 〈0.05), phosphorylated endothelial nitric oxide synthase protein expression (88.89±4.98 vs. 117.98±16.49, P 〈0.05) and nitric oxide production ((25.11±5.27) Iμmol/L vs. (37.72±7.10) μmol/L, P 〈0.05) were remarkably lower in endothelial cells from the chronic obstructive pulmonary disease group than the control. Conclusion Circulating endothelial progenitor cells were decreased and functionally impaired in patients with chronic obstructive pulmonary disease.
11-2154/R
circulating endothelial progenitor cells; chronic obstructive pulmonary disease; endothelial nitric oxide synthase; nitric oxide
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.3760/cma.j.issn.0366-6999.20122633
PMID 24033940
PQID 1433272547
PQPubID 23479
PageCount 6
ParticipantIDs wanfang_journals_zhcmj201317005
proquest_miscellaneous_1433272547
pubmed_primary_24033940
crossref_primary_10_3760_cma_j_issn_0366_6999_20122633
crossref_citationtrail_10_3760_cma_j_issn_0366_6999_20122633
chongqing_primary_47076682
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-00-00
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013-00-00
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Chinese medical journal
PublicationTitleAlternate Chinese Medical Journal
PublicationTitle_FL Chinese Medical Journal
PublicationYear 2013
Publisher Department of Geriatrics, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Departement of Rehabilitation Medicine, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Respiratory Medicine, Hunan Provincial People's Hospital, Changsha, 410005, China%Department of Respiratory Medicine ,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Intensive Care Unit,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China
Publisher_xml – name: Department of Geriatrics, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Departement of Rehabilitation Medicine, Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Respiratory Medicine, Hunan Provincial People's Hospital, Changsha, 410005, China%Department of Respiratory Medicine ,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China%Department of Intensive Care Unit,Second Xiangya Hospital of Central South University, Changsha,Hunan 410011, China
References Cella (R13-6-20231228) 2001; 7
Takahashi (R19-6-20231228) 2011; 16
Cai (R2-6-20231228) 2009; 14
Grisar (R10-6-20231228) 2008; 47
Cho (R14-6-20231228) 2003; 108
Fadini (R12-6-20231228) 2006; 26
Hristov (R5-6-20231228) 2004; 8
Durham (R23-6-20231228) 2010; 2
Qiu (R21-6-20231228) 2012; 185
Voelkel (R4-6-20231228) 2011; 1
Urbich (R15-6-20231228) 2004; 95
Vasa (R9-6-20231228) 2001; 89
Fadini (R16-6-20231228) 2006; 24
Hristov (R8-6-20231228) 2003; 13
Palange (R17-6-20231228) 2006; 27
George (R6-6-20231228) 2011; 4
Miller-Kasprzak (R7-6-20231228) 2007; 55
Sala (R18-6-20231228) 2010; 188
Liu (R20-6-20231228) 2012; 363
Fadini (R11-6-20231228) 2006; 49
Sood (R24-6-20231228) 2010; 182
Barr (R3-6-20231228) 2011; 8
Zhang (R1-6-20231228) 2008; 121
Sakao (R22-6-20231228) 2011; 16
References_xml – volume: 363
  start-page: 53
  year: 2012
  ident: R20-6-20231228
  article-title: Human endothelial progenitor cells isolated from COPD patients are dysfunctional.
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-011-1157-y
– volume: 13
  start-page: 201
  year: 2003
  ident: R8-6-20231228
  article-title: Endothelial progenitor cells: isolation and characterization.
  publication-title: Trends Cardiovasc Med
  doi: 10.1016/S1050-1738(03)00077-X
– volume: 24
  start-page: 1806
  year: 2006
  ident: R16-6-20231228
  article-title: Circulating progenitor cells are reduced in patients with severe lung disease.
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2005-0440
– volume: 4
  start-page: 24
  year: 2011
  ident: R6-6-20231228
  article-title: Endothelial progenitor cell biology in disease and tissue regeneration.
  publication-title: J Hematol Oncol
  doi: 10.1186/1756-8722-4-24
– volume: 7
  start-page: 205
  year: 2001
  ident: R13-6-20231228
  article-title: Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease.
  publication-title: Clin Appl Thromb Hemost
  doi: 10.1177/107602960100700304
– volume: 89
  start-page: E1
  year: 2001
  ident: R9-6-20231228
  article-title: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.
  publication-title: Circ Res
  doi: 10.1161/hh1301.093953
– volume: 47
  start-page: 1476
  year: 2008
  ident: R10-6-20231228
  article-title: Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells.
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/ken286
– volume: 1
  start-page: 320
  year: 2011
  ident: R4-6-20231228
  article-title: COPDemphysema: the vascular story.
  publication-title: Pulm Circ
  doi: 10.4103/2045-8932.87295
– volume: 121
  start-page: 597
  year: 2008
  ident: R1-6-20231228
  article-title: Inhibition of tumor necrosis factor-alpha reduces alveolar septal cell apoptosis in passive smoking rats.
  publication-title: Chin Med J
  doi: 10.1097/00029330-200804010-00005
– volume: 188
  start-page: 331
  year: 2010
  ident: R18-6-20231228
  article-title: Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD.
  publication-title: Lung
  doi: 10.1007/s00408-009-9225-8
– volume: 95
  start-page: 343
  year: 2004
  ident: R15-6-20231228
  article-title: Endothelial progenitor cells: characterization and role in vascular biology.
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000137877.89448.78
– volume: 26
  start-page: 2140
  year: 2006
  ident: R12-6-20231228
  article-title: Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy.
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000237750.44469.88
– volume: 8
  start-page: 522
  year: 2011
  ident: R3-6-20231228
  article-title: The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema.
  publication-title: Proc Am Thorac Soc
  doi: 10.1513/pats.201101-008MW
– volume: 2
  start-page: 523
  year: 2010
  ident: R23-6-20231228
  article-title: Epigenetics in asthma and other inflammatory lung diseases.
  publication-title: Epigenomics
  doi: 10.2217/epi.10.27
– volume: 55
  start-page: 247
  year: 2007
  ident: R7-6-20231228
  article-title: Endothelial progenitor cells as a new agent contributing to vascular repair.
  publication-title: Arch Immunol Ther Exp (Warsz)
  doi: 10.1007/s00005-007-0027-5
– volume: 16
  start-page: 1056
  year: 2011
  ident: R22-6-20231228
  article-title: The importance of epigenetics in the development of chronic obstructive pulmonary disease.
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2011.02032.x
– volume: 49
  start-page: 3075
  year: 2006
  ident: R11-6-20231228
  article-title: Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats.
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0401-6
– volume: 108
  start-page: 2918
  year: 2003
  ident: R14-6-20231228
  article-title: Mobilized endothelial progenitor cells by granulocytema crophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation.
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000097001.79750.78
– volume: 16
  start-page: 680
  year: 2011
  ident: R19-6-20231228
  article-title: Impaired endothelial progenitor cell mobilization and colonyforming capacity in chronic obstructive pulmonary disease.
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2011.01959.x
– volume: 14
  start-page: 354
  year: 2009
  ident: R2-6-20231228
  article-title: Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2009.01511.x
– volume: 182
  start-page: 1098
  year: 2010
  ident: R24-6-20231228
  article-title: Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers.
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201002-0222OC
– volume: 8
  start-page: 498
  year: 2004
  ident: R5-6-20231228
  article-title: Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2004.tb00474.x
– volume: 27
  start-page: 529
  year: 2006
  ident: R17-6-20231228
  article-title: Circulating haemopoietic and endothelial progenitor cells are decreased in COPD.
  publication-title: Eur Respir J
  doi: 10.1183/09031936.06.00120604
– volume: 185
  start-page: 373
  year: 2012
  ident: R21-6-20231228
  article-title: Variable DNA methylation is associated with COPD and lung function.
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201108-1382OC
SSID ssj0025576
Score 2.0322447
Snippet Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In...
It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications. In order to...
Background It has been widely demonstrated that endothelial progenitor cells are involved in several diseases and that they have therapeutic implications.In...
SourceID wanfang
proquest
pubmed
crossref
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3222
SubjectTerms AC133 Antigen
Aged
Aged, 80 and over
Antigens, CD - metabolism
Antigens, CD34 - metabolism
Endothelial Cells - metabolism
Endothelial Cells - pathology
Female
Glycoproteins - metabolism
Humans
Male
Middle Aged
Peptides - metabolism
Pulmonary Disease, Chronic Obstructive - metabolism
Pulmonary Disease, Chronic Obstructive - pathology
Stem Cells - metabolism
Stem Cells - pathology
Vascular Endothelial Growth Factor Receptor-2 - metabolism
内皮型一氧化氮合酶
内皮祖细胞
功能失调
外周血单个核细胞
循环
患者
慢性阻塞性肺疾病
细胞增殖能力
Title Decreased and dysfunctional circulating endothelial progenitor cells in patients with chronic obstructive pulmonary disease
URI http://lib.cqvip.com/qk/85656X/201317/47076682.html
https://www.ncbi.nlm.nih.gov/pubmed/24033940
https://www.proquest.com/docview/1433272547
https://d.wanfangdata.com.cn/periodical/zhcmj201317005
Volume 126
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV3db9MwELfGJk28IGB8dMAIEn6KOpI0thOJl7bLWk1iTDCk7inKh9t12tKxtkgb_zx3tpOmY4INabxESZz4kpzz8_n8uzMh71nKU47sKWeY-k1_mAAO5sxp-mCNp9xJGUsxdvjTPu9_8_cGbLCytlFjLc1n6XZ2dWNcyb9oFc6BXjFK9g6arSqFE7AP-oUtaBi2t9LxjrL5plKlW7Xzyyn2Usa5l40vMrU0VzGyZZFjoNUpeseRkCXxP76w0WmvaeQ6uaqJdMt0vlx7kprksj-kfT4_hbdChl19RscYtTTyaSeg7R0aMRrs0CBSO13a6eAOnG9zGnEaQpGHZzq7NBQ02qWdLg0CGgU06NCOq67hNIAiQYNQFelrKm_FUXu_Zx_Nq9bYa-_bR9VRt_3Z3ptXzb3bj6DUNH_j2dAhqZqYAj3xxawkQ_RQYbhcgWrYX9FPkNsD-HlGl0m1uooir2h_uK0WH6wRWwx5oRjpObT-vADo9DH5lKuLxhh-x7RUWYr9spQpXc-bjbWX-b6fYfEIC7ZFXb6--0D5nNTEyoGKNlAzPOXDXBOoZDnsbrIAfbr_610XERsYeKdGXPcnvdbJtjhv8lAv0lVZBDqJQwl9otbB48RkzViEQ3GTIYJUM0CP7CzZPlGCtitBSCeFMY9O_3It1_vVcXZ2gr8CZs1kD8iaJ4SLROXeoCKueYwJw8DQFa4TaiR--KM8zB5zPClG3wF4lq3w34bWKoKxGMJHrBnbh4_JIzNKttoa8p6QFVk8Jetlg9kgPyvkswD5rCXks2rIZ9WQz1ogn6WQzxoXVol8FiKfZZDPqiGfVSGfZZDvGfm2Gx12-02zjEwz81ti1hRpy83DXHKPSUxHmnos58j3ANOk5fLUk1wykQ9bSea4aSg913fd3EuGLEX7Z9h6TlaLSSFfEiuAwVAoeZYOsxCs_yBhoe9LV6SJyJMwcxtks_rE8blOFxT7whGcB16DfCy_eZwZWMF1gE5j14lRfTGoLz6JUX0xqi9G9cWl-hqEV7eXVd_yxnelgmOwHfALJ4WczKexi8krhcd80SAvtOarqjFPayv0nQZ5a5pCbHq-abzcTDf_esUr8tBTqwih5_o1WQUVyjcwlpulW8oHuqUa-C8wEZu1
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decreased+and+dysfunctional+circulating+endothelial+progenitor+cells+in+patients+with+chronic+obstructive+pulmonary+disease&rft.jtitle=%E4%B8%AD%E5%8D%8E%E5%8C%BB%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%88%E8%8B%B1%E6%96%87%E7%89%88%EF%BC%89&rft.au=YANG+Yue&rft.au=GAN+Ye&rft.au=CAO+Jun&rft.au=CHEN+Yan&rft.date=2013&rft.pub=Department+of+Geriatrics%2C+Second+Xiangya+Hospital+of+Central+South+University%2C+Changsha%2CHunan+410011%2C+China%25Departement+of+Rehabilitation+Medicine%2C+Second+Xiangya+Hospital+of+Central+South+University%2C+Changsha%2CHunan+410011%2C+China%25Department+of+Respiratory+Medicine%2C+Hunan+Provincial+People%27s+Hospital%2C+Changsha%2C+410005%2C+China%25Department+of+Respiratory+Medicine+%2CSecond+Xiangya+Hospital+of+Central+South+University%2C+Changsha%2CHunan+410011%2C+China%25Department+of+Intensive+Care+Unit%2CSecond+Xiangya+Hospital+of+Central+South+University%2C+Changsha%2CHunan+410011%2C+China&rft.issn=0366-6999&rft.volume=126&rft.issue=17&rft.spage=3222&rft.epage=3227&rft_id=info:doi/10.3760%2Fcma.j.issn.0366-6999.20122633&rft.externalDocID=zhcmj201317005
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85656X%2F85656X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg